NCT06927271Recruiting
Effectiveness of Phone Call and Video-based Interventions to Improve Adherence to Medications in Hypertensive Patients
Effectiveness, Cost-effectiveness, and Acceptability of Phone Call and Video-based Interventions to Improve Adherence to Antihypertensive Medications
Source: ClinicalTrials.gov · Last updated 15 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to find out if phone call and video-based interventions that seek to educate people with uncontrolled high blood pressure and also remind them to take their medicines will improve adherence to their medicines. It will also examine if the interventions are economical to implement. The main objectives of the study are: * Design videos and phone call-based interventions for people with hypertension. * Examine the effect of videos and phone call-based intervention on adherence to medication in people with hypertension. * Calculate the costs associated with the mobile health intervention * Examine the factors influencing acceptance of video and phone calls based interventions for improving adherence to antihypertensive medications among patients Participants will: * Receive the intervention thrice weekly for 3 months * Visit the health facility at the end of 3 months for check up and measurement of outcome variables (adherence and blood pressure). Additionally, at the end of 3 months, the acceptability of the interventions will be measured among the participants who received either phone call or video. Researchers will compare the two groups (one group will utilize phone call whereas the other videos) with the control group to see if the mobile interventions improve adherence to medicines. Only adults 18 years and above in selected health facilities in the Eastern will participate in the study. The selected participants should have uncontrolled blood pressure based on readings from last 2 visits. To be included in the study, the participants need to own a smartphone.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1400 (estimated)
- First submitted
- 17 Jan 2025
- Start date
- 24 Feb 2025
- Primary completion date
- 30 Aug 2025
- Lead sponsor
- University of Ghana
- Diseases
- High blood pressure, Type 2 diabetes
- NCT number
- NCT06927271
What you commit to
- Study type: Interventional
- Planned participants: 1400
- From 24 Feb 2025 to the primary completion date, 30 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participating in another mobile health intervention or medication adherence intervention
Other illness
- Pregnant women with hypertension or within 3 months postpartum
- Hypertensive patients with diabetes, liver failure or kidney disease
- has a psychiatric disease or mental illness 6) has a visual impairment.
Other
- Plans to travel out of the country during the period of the study
Who the study is looking for
- adult aged 18 years or older
- diagnosed of hypertension
- has uncontrolled hypertension (i.e. systolic blood pressure ≥140 mmHg and a diastolic blood pressure ≥ 90mmHg) documented in their records on 2 clinic visits
- has been prescribed at least one antihypertensive medication for a period of 2 months before the study
- owns a smart phone or has access to one at all times.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| St Joseph Catholic Hospital Coordinator of this site? Confirm its status | Efiduase | Ghana | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.